Serial ‘deep-sampling’ PCR of fragmented DNA reveals the wide range of Trypanosoma cruzi burden among chronically infected human, macaque, and canine hosts, and allows accurate monitoring of parasite load following treatment
eLife · 2025
DOI: 10.7554/elife.104547 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Brooke E White und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Tropical and Emerging Global Disease, Athens, United States. Hauptthemen laut MEDLINE: Trypanosoma cruzi, Chagas Disease, Parasite Load, Polymerase Chain Reaction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCATS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Infection with the protozoan parasite Trypanosoma cruzi is generally well-controlled by host immune responses, but appears to be rarely eliminated. The resulting persistent, low-level infection results in cumulative tissue damage with the greatest impact generally in the heart in the form of chagasic cardiomyopathy. The relative success in immune control of T. cruzi infection usually averts acute phase death but has the negative consequence that the low-level presence of T. cruzi in hosts is challenging to detect unequivocally. Thus, it is difficult to identify those who are actively infected and, as well, problematic to gauge the impact of treatment, particularly in the evaluation of the relative efficacy of new drugs. In this study, we employ DNA fragmentation and high numbers of replicate PCR reaction (‘deep-sampling’) and to extend the quantitative range of detecting T. cruzi in blood by at least three orders of magnitude relative to current protocols. When combined with sampling blood at multiple time points, deep sampling of fragmented DNA allowed for detection of T. cruzi in all infected hosts in multiple host species, including humans, macaques, and dogs. In addition, we provide evidence for a number of characteristics not previously rigorously quantified in the population of hosts with naturally acquired T. cruzi infection, including, a >6 log variation between chronically infected individuals in the stable parasite levels, a continuing decline in parasite load during the second and third years of infection in some hosts, and the potential for parasite load to change dramatically when health conditions change. Although requiring strict adherence to contamination–prevention protocols and significant resources, deep-sampling PCR provides an important new tool for assessing therapies and for addressing long-standing questions in T. cruzi infection and Chagas disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Tropical and Emerging Global Disease, Athens, United States.
- Michale E. Keeling Center for Comparative Medicine and Research, The University of Texas MD Anderson Cancer Center, Bastrop, United States.
- Department of Veterinary Integrative Biosciences, School of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, United States.
- Department of Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, United States.
- Research Department, Instituto Nacional de Parasitología "Dr. Mario Fatala Chaben", Buenos Aires, Argentina. Chagas Disease Unit, Hospital Interzonal General de Agudos Eva Perón, Buenos Aires, Argentina.
- Department of Statistics, University of Georgia, Athens, United States.
ORCID-Profile: Rick L Tarleton
Förderung
- NIAID NIH HHS
- NCATS NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
White, B. E., Hodo, C. L., Hamer, S., Saunders, A. B., Laucella, S. A., Hall, D. B., & Tarleton, R. L. (2025). Serial ‘deep-sampling’ PCR of fragmented DNA reveals the wide range of Trypanosoma cruzi burden among chronically infected human, macaque, and canine hosts, and allows accurate monitoring of parasite load following treatment. eLife. https://doi.org/10.7554/elife.104547
Vancouver
White BE, Hodo CL, Hamer S, Saunders AB, Laucella SA, Hall DB, et al. Serial ‘deep-sampling’ PCR of fragmented DNA reveals the wide range of Trypanosoma cruzi burden among chronically infected human, macaque, and canine hosts, and allows accurate monitoring of parasite load following treatment. eLife. 2025. doi:10.7554/elife.104547
BibTeX
@article{White2025,
author = {White, Brooke E and Hodo, Carolyn L and Hamer, Sarah and Saunders, Ashley B and Laucella, Susana A and Hall, Daniel B and Tarleton, Rick L},
title = {Serial ‘deep-sampling’ PCR of fragmented DNA reveals the wide range of Trypanosoma cruzi burden among chronically infected human, macaque, and canine hosts, and allows accurate monitoring of parasite load following treatment},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.104547}
}
EUVIMED